Table of Contents
ISRN Pharmaceutics
Volume 2011, Article ID 981254, 7 pages
http://dx.doi.org/10.5402/2011/981254
Clinical Study

Randomized, Double-Blind, and Placebo-Controlled Trial of Clenbuterol in Denervated Muscle Atrophy

1Department of Hand Surgery, Huashan Hospital of Fudan University, Shanghai 200040, China
2Clinical Development, Neurology & Pain, R&D, Allergan Inc., 2525 Dupont Dr., Irvine, CA 92612, USA

Received 1 June 2011; Accepted 21 June 2011

Academic Editors: M. Cabeza and J. K. Lalla

Copyright © 2011 Guang-Liang Jiang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. G. Ryall and G. S. Lynch, “The potential and the pitfalls of β-adrenoceptor agonists for the management of skeletal muscle wasting,” Pharmacology and Therapeutics, vol. 120, no. 3, pp. 219–232, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Sneddon, M. I. Delday, and C. A. Maltin, “Amelioration of denervation-induced atrophy by clenbuterol is associated with increased PKC-α activity,” American Journal of Physiology—Endocrinology and Metabolism, vol. 279, no. 1, pp. E188–E195, 2000. View at Google Scholar
  3. R. T. Hinkle, K. M. B. Hodge, D. B. Cody, R. J. Sheldon, B. K. Kobilka, and R. J. Isfort, “Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the β2-adrenergic receptor,” Muscle and Nerve, vol. 25, no. 5, pp. 729–734, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. W. N. Smith, A. Dirks, T. Sugiura, S. Muller, P. Scarpace, and S. K. Powers, “Alteration of contractile force and mass in the senescent diaphragm with β2-agonist treatment,” Journal of Applied Physiology, vol. 92, no. 3, pp. 941–948, 2002. View at Google Scholar · View at Scopus
  5. Y. D. Teng, H. Choi, W. Huang et al., “Therapeutic effects of clenbuterol in a murine model of amyotrophic lateral sclerosis,” Neuroscience Letters, vol. 397, no. 1-2, pp. 155–158, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. L. J. Harcourt, J. D. Schertzer, J. G. Ryall, and G. S. Lynch, “Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue,” Neuromuscular Disorders, vol. 17, no. 1, pp. 47–55, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. K. M. Cancelliero, J. L. Q. Durigan, R. P. Vieira, C. A. Silva, and M. L. O. Polacow, “The effect of a low dose of clenbuterol on rat soleus muscle submitted to joint immobilization,” Brazilian Journal of Medical and Biological Research, vol. 41, no. 12, pp. 1054–1058, 2008. View at Google Scholar · View at Scopus
  8. G. K. R. Soppa, J. Lee, M. A. Stagg et al., “Role and possible mechanisms of clenbuterol in enhancing reverse remodelling during mechanical unloading in murine heart failure,” Cardiovascular Research, vol. 77, no. 4, pp. 695–706, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Maltin, M. I. Delday, J. S. Watson et al., “Clenbuterol, a β-adrenoceptor agonist, increases relative muscle strength in orthopaedic patients,” Clinical Science, vol. 84, no. 6, pp. 651–654, 1993. View at Google Scholar · View at Scopus
  10. J. T. Kissel, M. P. McDermott, J. R. Mendell et al., “Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy,” Neurology, vol. 57, no. 8, pp. 1434–1440, 2001. View at Google Scholar · View at Scopus
  11. C. L. Skura, E. G. Fowler, G. T. Wetzel, M. Graves, and M. J. Spencer, “Albuterol increases lean body mass in ambulatory boys with Duchenne or Becker muscular dystrophy,” Neurology, vol. 70, no. 2, pp. 137–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. E. J. Birks, P. D. Tansley, J. Hardy et al., “Left ventricular assist device and drug therapy for the reversal of heart failure,” The New England Journal of Medicine, vol. 355, no. 18, pp. 1873–1884, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. I. George, S. Xydas, D. M. Mancini et al., “Effect of clenbuterol on cardiac and skeletal muscle function during left ventricular assist device support,” Journal of Heart and Lung Transplantation, vol. 25, no. 9, pp. 1084–1090, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Kamalakkannan, C. M. Petrilli, I. George et al., “Clenbuterol increases lean muscle mass but not endurance in patients with chronic heart failure,” Journal of Heart and Lung Transplantation, vol. 27, no. 4, pp. 457–461, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. W. J. Carter and M. E. Lynch, “Comparison of the effects of salbutamol and clenbuterol on skeletal muscle mass and carcass composition in senescent rats,” Metabolism, vol. 43, no. 9, pp. 1119–1125, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. R. J. Pack, M. R. Alley, J. A. Dallimore, K. R. Lapwood, C. Burgess, and J. Crane, “The myocardial effects of fenoterol, isoprenaline and salbutamol in normoxic and hypoxic sheep,” International Journal of Experimental Pathology, vol. 75, no. 5, pp. 357–362, 1994. View at Google Scholar · View at Scopus
  17. K. Wong, K. R. Boheler, J. Bishop, M. Petrou, and M. H. Yacoub, “Clenbuterol induces cardiac hypertrophy with normal functional, morphological and molecular features,” Cardiovascular Research, vol. 37, no. 1, pp. 115–122, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. J. G. Baker, “The selectivity of β-adrenoceptor agonists at human β1-, β2- and β3-adrenoceptors,” British Journal of Pharmacology, vol. 160, no. 5, pp. 1048–1061, 2010. View at Publisher · View at Google Scholar
  19. S. C. Lien, P. S. Cederna, and W. M. Kuzon Jr., “Optimizing skeletal muscle reinnervation with nerve transfer,” Hand Clinics, vol. 24, no. 4, pp. 445–454, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. G. L. Jiang, L. Y. Zhang, L. Y. Shen, J. G. Xu, and Y. D. Gu, “Fibrillation potential amplitude to quantitatively assess denervation muscle atrophy,” Neuromuscular Disorders, vol. 10, no. 2, pp. 85–91, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. G. H. Kraft, “Fibrillation potential amplitude and muscle atrophy following peripheral nerve injury,” Muscle and Nerve, vol. 13, no. 9, pp. 814–821, 1990. View at Publisher · View at Google Scholar · View at Scopus
  22. R. C. Srinivasan, M. P. Lungren, J. E. Langenderfer, and R. E. Hughes, “Fiber type composition and maximum shortening velocity of muscles crossing the human shoulder,” Clinical Anatomy, vol. 20, no. 2, pp. 144–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. M. R. Deschenes, M. A. Roby, M. K. Eason, and M. B. Harris, “Remodeling of the neuromuscular junction precedes sarcopenia related alterations in myofibers,” Experimental Gerontology, vol. 45, no. 5, pp. 389–393, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Sakuma and A. Yamaguchi, “Molecular mechanisms in aging and current strategies to counteract sarcopenia,” Current Aging Science, vol. 3, no. 2, pp. 90–101, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. C. A. Maltin, M. I. Delday, S. M. Hay, and A. G. S. Baillie, “Denervation increases clenbuterol sensitivity in muscle from young rats,” Muscle and Nerve, vol. 15, no. 2, pp. 188–192, 1992. View at Google Scholar · View at Scopus
  26. H. Wang, Y. Gu, J. Xu, L. Shen, and J. Li, “Comparative study of different surgical procedures using sensory nerves or neurons for delaying atrophy of denervated skeletal muscle,” Journal of Hand Surgery, vol. 26, no. 2, pp. 326–331, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. C. M. Galtrey, R. A. Asher, F. Nothias, and J. W. Fawcett, “Promoting plasticity in the spinal cord with chondroitinase improves functional recovery after peripheral nerve repair,” Brain, vol. 130, no. 4, pp. 926–939, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. O. Frerichs, H. Fansa, P. Ziems, W. Schneider, and G. Keilhoff, “Regeneration of peripheral nerves after clenbuterol treatment in a rat model,” Muscle and Nerve, vol. 24, no. 12, pp. 1687–1691, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. R. J. Zeman, H. Peng, and J. D. Etlinger, “Clenbuterol retards loss of motor function in motor neuron degeneration mice,” Experimental Neurology, vol. 187, no. 2, pp. 460–467, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. R. S. Williams, M. G. Caron, and K. Daniel, “Skeletal muscle beta-adrenergic receptors: variations due to fiber type and training,” The American journal of physiology, vol. 246, no. 2, pp. E160–167, 1984. View at Google Scholar · View at Scopus
  31. Y. S. Kim, R. D. Sainz, P. Molenaar, and R. J. Summers, “Characterization of β1- and β2-adrenoceptors in rat skeletal muscles,” Biochemical Pharmacology, vol. 42, no. 9, pp. 1783–1789, 1991. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Sato, S. Nomura, F. Kawano, J. Tanihata, K. Tachiyashiki, and K. Imaizumi, “Effects of the β2-agonist clenbuterol on β1- and β2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles,” Journal of Pharmacological Sciences, vol. 107, no. 4, pp. 393–400, 2008. View at Publisher · View at Google Scholar
  33. P. K. Bhavsar, N. J. Brand, L. E. Felkin et al., “Clenbuterol induces cardiac myocyte hypertrophy via paracrine signalling and fibroblast-derived IGF-1,” Journal of Cardiovascular Translational Research, vol. 3, no. 6, pp. 688–695, 2010. View at Google Scholar
  34. J. G. Burniston, W. A. Clark, L. B. Tan, and D. F. Goldspink, “Dose dependent separation of the hypertrophic and myotoxic effects of the β2 agonist clenbuterol in rat striated muscles,” Muscle and Nerve, vol. 33, no. 5, pp. 655–663, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. L. Boner, D. Bennati, C. Castellani, L. Sette, and M. Schiassi, “Bronchodilating activity of oral clenbuterol in asthmatic children after single administration of different dosages,” Pediatric Pulmonology, vol. 3, no. 1, pp. 34–37, 1987. View at Google Scholar · View at Scopus